Victory Capital Management Inc Evolus, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$7.76 - $13.72 $149,558 - $264,425	19,273 Added 93.21%	39,949 $322,000
Q2 2022 Aug 01, 2022	BUY	$10.22 - $13.94 $211,308 - $288,223	20,676 New	20,676 $240,000
Q2 2020 Aug 07, 2020	SELL	$3.53 - $6.17 $15,260 - $26,672	-4,323 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$3.53 - $12.21 $3 - $12	1 Added 0.02%	4,323 $18,000
Q4 2019 Feb 04, 2020	SELL	$11.58 - $17.37 $31,833 - $47,750	-2,749 Reduced 38.88%	4,322 $44,000
Q3 2019 Nov 12, 2019	BUY	$13.91 - $19.87 $98,357 - $140,500	7,071 New	7,071 $110,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.